Does first line antiretroviral therapy increase the prevalence of cardiovascular risk factors in Indian patients? | Zendy

RAB Carey | Zendy; Priscilla Rupali | Zendy; OC Abraham | Zendy; Deepthi Kattula | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Does first line antiretroviral therapy increase the prevalence of cardiovascular risk factors in Indian patients?

Author(s) -

RAB Carey,

Priscilla Rupali,

OC Abraham,

Deepthi Kattula

Publication year - 2013

Publication title -

journal of postgraduate medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.405

H-Index - 52

eISSN - 0972-2823

pISSN - 0022-3859

DOI - 10.4103/0022-3859.123145

Subject(s) - medicine , dyslipidemia , hypertriglyceridemia , lipodystrophy , cross sectional study , diabetes mellitus , obesity , antiretroviral therapy , viral load , human immunodeficiency virus (hiv) , immunology , triglyceride , endocrinology , cholesterol , pathology

Antiretroviral therapy (ART) is associated with a myriad of metabolic complications which are potential cardiovascular risk factors. Early detection of these risk factors could help in alleviating morbidity and mortality in human immunodeficiency virus (HIV) infected patients on ART.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research